Brazil remains outside the European Union's approved list of exporters for animals and animal-origin products following a regulatory update by the European Commission.

This exclusion threatens the flow of animal products from one of the world's largest agricultural exporters to the European market. The decision centers on the bloc's tightening standards for how antimicrobial agents are used in animal production, creating a significant trade barrier for Brazilian producers.

The European Commission published the updated regulation on June 5, 2024 [1]. The new rules establish specific requirements for the use of antimicrobials in livestock to ensure human consumption safety. Brazil did not satisfy these new standards, which are mandatory for any country wishing to be included on the EU's approved exporter list [1].

Fernando Henrique Iglesias, an analyst at Safras & Mercado, said the exclusion is a result of the gap between Brazilian production practices and the EU's regulatory demands. The European Commission's decision reflects a broader push within the union to reduce antimicrobial resistance in the food chain, a priority that now dictates market access for third-party nations.

Under the current framework, countries must demonstrate compliance with the EU's antimicrobial-use protocols to maintain or gain export status. Because Brazil does not meet these requirements, its animal-origin products face restricted access to the European market [1].

The regulatory shift highlights the increasing friction between global agricultural output and the European Union's stringent environmental and health mandates. While Brazil continues to lead in meat and animal product exports globally, the EU's shift toward stricter antimicrobial controls creates a technical hurdle that requires systemic changes in Brazilian farming practices to resolve.

“Brazil remains outside the European Union's approved list of exporters for animals and animal-origin products.”

This regulatory move signals the EU's transition from voluntary guidelines to mandatory enforcement regarding antimicrobial use in global supply chains. For Brazil, the exclusion is not merely a bureaucratic delay but a signal that its current animal production model may be incompatible with the EU's evolving health and science standards, potentially forcing a shift in domestic farming practices to regain market access.